{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:48Z","timestamp":1792783128232,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ongoing Research Funding program ), King Saud University, Riyadh, Saudi Arabia.","award":["ORF-2026-131"],"award-info":[{"award-number":["ORF-2026-131"]}],"id":[{"id":"https:\/\/ror.org\/02f81g417","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00948-6","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:52:51Z","timestamp":1790257971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design, synthesis, in vivo, and in silico evaluation of novel quinoline-based dihydrothiazoles as anticonvulsants"],"prefix":"10.1007","volume":"40","author":[{"given":"Faiqa","family":"Noreen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Hussain","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Basri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4358-5259","authenticated-orcid":false,"given":"Farhan","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faleh","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajmal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"948_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107662","volume":"151","author":"A Karak\u00fc\u00e7\u00fck-\u0130yido\u011fan","year":"2024","unstructured":"Karak\u00fc\u00e7\u00fck-\u0130yido\u011fan A et al (2024) Development of new chiral 1, 2, 4-triazole-3-thiones and 1, 3, 4-thiadiazoles with promising in vivo anticonvulsant activity targeting GABAergic system and voltage-gated sodium channels (VGSCs). Bioorg Chem 151:107662","journal-title":"Bioorg Chem"},{"issue":"4","key":"948_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2023.104610","volume":"16","author":"N Rasool","year":"2023","unstructured":"Rasool N et al (2023) A facile synthesis of 1, 3, 4-oxadiazole-based carbamothioate molecules: antiseizure potential, EEG evaluation and in-silico docking studies. Arab J Chem 16(4):104610","journal-title":"Arab J Chem"},{"key":"948_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2022.129042","volume":"77","author":"AG Alhamzani","year":"2022","unstructured":"Alhamzani AG et al (2022) Design, synthesis, molecular docking and pharmacological evaluation of novel triazine-based triazole derivatives as potential anticonvulsant agents. Bioorg Med Chem Lett 77:129042","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"948_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202401620","volume":"22","author":"P Singh","year":"2025","unstructured":"Singh P et al (2025) Recent progresses in development of heterocyclic compounds for epilepsy treatment: key research highlights from 2019\u20132024. Chem Biodivers 22(1):e202401620","journal-title":"Chem Biodivers"},{"issue":"4","key":"948_CR5","first-page":"193","volume":"67","author":"FF Alshehri","year":"2024","unstructured":"Alshehri FF et al (2024) Study, docking, in silico ADME and bio-evaluation of novel hetero-aromatic amino acid derivatives as potential anti-epileptic agents. Egypt J Chem 67(4):193\u2013206","journal-title":"Egypt J Chem"},{"issue":"1s","key":"948_CR6","doi-asserted-by":"publisher","first-page":"s80","DOI":"10.5530\/ijper.58.1s.8","volume":"58","author":"S Tyagi","year":"2024","unstructured":"Tyagi S et al (2024) Synthesis, characterization, in silico and in vivo evaluation of amino acid derived Schiff bases of quinoline-benzimidazole hybrids as anti-epileptic agents. Indian J Pharm Educ Res 58(1s):s80\u2013s92","journal-title":"Indian J Pharm Educ Res"},{"key":"948_CR7","doi-asserted-by":"publisher","first-page":"1580943","DOI":"10.3389\/fphar.2025.1580943","volume":"16","author":"M Dahalia","year":"2025","unstructured":"Dahalia M et al (2025) In vitro and in-vivo exploration of physostigmine analogues to understand the mechanistic crosstalk between Klotho and targets for epilepsy. Front Pharmacol 16:1580943","journal-title":"Front Pharmacol"},{"issue":"2","key":"948_CR8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1080\/10406638.2023.2183969","volume":"44","author":"D Tiglani","year":"2024","unstructured":"Tiglani D et al (2024) Synthesis anticonvulsant and cytotoxic evaluation of benzimidazole-quinoline hybrids schiff base analogs. Polycycl Aromat Compd 44(2):960\u2013980","journal-title":"Polycycl Aromat Compd"},{"key":"948_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.108117","volume":"155","author":"M Valipour","year":"2025","unstructured":"Valipour M et al (2025) Design, synthesis, and structure\u2013activity relationships of five-membered heterocyclic incorporated aryl (alkyl) azoles: from antiproliferative thiazoles to safer anticonvulsant oxadiazoles. Bioorg Chem 155:108117","journal-title":"Bioorg Chem"},{"key":"948_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117664","author":"B Lou","year":"2025","unstructured":"Lou B et al (2025) Discovery of novel 4-azaindole derivatives as selective Nav1. 2 inhibitor with potent antiepileptic activity and low neurotoxicity. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117664","journal-title":"Eur J Med Chem"},{"issue":"1","key":"948_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1747-0285.2011.01255.x","volume":"79","author":"S Kumar","year":"2012","unstructured":"Kumar S et al (2012) Design, synthesis and screening of quinoline-incorporated thiadiazole as a potential anticonvulsant. Chem Biol Drug Des 79(1):104\u2013111","journal-title":"Chem Biol Drug Des"},{"issue":"21","key":"948_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202300209","volume":"8","author":"K Shabana","year":"2023","unstructured":"Shabana K et al (2023) Synthesis, characterization, in silico and in vivo evaluation of benzimidazole-bearing quinoline Schiff bases as new anticonvulsant agents. ChemistrySelect 8(21):e202300209","journal-title":"ChemistrySelect"},{"key":"948_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.143878","author":"I Naseer","year":"2025","unstructured":"Naseer I et al (2025) Synthesis, antidiabetic assessment, metal chelating impacts, and computational modeling of 4-fluorophenyl sulfonyl-indole based hydrazones. J Mol Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2025.143878","journal-title":"J Mol Struct"},{"issue":"9","key":"948_CR14","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s40263-021-00827-8","volume":"35","author":"W L\u00f6scher","year":"2021","unstructured":"L\u00f6scher W, Klein P (2021) The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond. CNS Drugs 35(9):935\u2013963","journal-title":"CNS Drugs"},{"key":"948_CR15","doi-asserted-by":"publisher","DOI":"10.1055\/a-2564-4559","author":"D Chandra","year":"2025","unstructured":"Chandra D et al (2025) Quinoline based FDA approved drugs: synthetic route and clinical uses. Synlett. https:\/\/doi.org\/10.1055\/a-2564-4559","journal-title":"Synlett"},{"issue":"5","key":"948_CR16","doi-asserted-by":"publisher","first-page":"958","DOI":"10.2174\/0109298673258512231013060222","volume":"32","author":"Y Zhao","year":"2025","unstructured":"Zhao Y et al (2025) Quinolines: a promising heterocyclic scaffold for cancer therapeutics. Curr Med Chem 32(5):958\u2013973","journal-title":"Curr Med Chem"},{"issue":"3","key":"948_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27031003","volume":"27","author":"DJ Kucharski","year":"2022","unstructured":"Kucharski DJ, Jaszczak MK, Boraty\u0144ski PJ (2022) A review of modifications of quinoline antimalarials: mefloquine and (hydroxy) chloroquine. Molecules 27(3):1003","journal-title":"Molecules"},{"issue":"15","key":"948_CR18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2174\/1385272827666221021140934","volume":"26","author":"S Sharma","year":"2022","unstructured":"Sharma S, Singh S (2022) Synthetic routes to quinoline-based derivatives having potential anti-bacterial and anti-fungal properties. Curr Org Chem 26(15):1453\u20131469","journal-title":"Curr Org Chem"},{"key":"948_CR19","doi-asserted-by":"publisher","DOI":"10.62946\/IJMPHS\/1.2.65-79","author":"R Chawla","year":"2024","unstructured":"Chawla R, Vaidya A (2024) Anticancer mechanism of quinoline based compounds for cancer therapy. International Journal of Medical Pharmaceutical and Health Sciences. https:\/\/doi.org\/10.62946\/IJMPHS\/1.2.65-79","journal-title":"International Journal of Medical Pharmaceutical and Health Sciences"},{"issue":"2","key":"948_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00044-024-03346-5","volume":"34","author":"A Shetnev","year":"2025","unstructured":"Shetnev A et al (2025) Monoamine oxidase inhibition by thiazole derivatives substituted with the benzenesulfonamide moiety. Med Chem Res 34(2):357\u2013366","journal-title":"Med Chem Res"},{"key":"948_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117327","author":"F Hussain","year":"2025","unstructured":"Hussain F et al (2025) Promising thiazolidinedione-thiazole based multi-target and neuroprotective hybrids for Alzheimer\u2019s disease: design, synthesis, in-vitro, in-vivo and in-silico studies. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117327","journal-title":"Eur J Med Chem"},{"key":"948_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108390","volume":"159","author":"R Aggarwal","year":"2025","unstructured":"Aggarwal R et al (2025) Synthesis and biological evaluation of novel trifluoromethylated arylidene-hydrazinyl-thiazoles as neuroprotective agents. Bioorg Chem 159:108390","journal-title":"Bioorg Chem"},{"issue":"1","key":"948_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13065-025-01421-5","volume":"19","author":"RE Abdelwahab","year":"2025","unstructured":"Abdelwahab RE et al (2025) Synthesis, and antibacterial activities of novel 1, 3, 4a, 9-tetraza-4 H-fluoren-2-amines incorporating phenoxy-N-arylacetamide, pyrazole, and 2-(4-(1-phenyl-1 H-pyrazol-3-yl) phenoxy)-N-arylacetamide moieties. BMC Chem 19(1):61","journal-title":"BMC Chem"},{"key":"948_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140814","volume":"1324","author":"R Kumar","year":"2025","unstructured":"Kumar R et al (2025) Integration of in-vivo screening, molecular docking, and molecular dynamics simulations for studying the antiepileptic potential of newly synthesized 5-naphthalen-1-yl-5, 10-dihydro-1H-pyrimido [4, 5-b] quinoline-2, 4-diones in optimized reaction conditions by utilizing l-proline as green catalyst. J Mol Struct 1324:140814","journal-title":"J Mol Struct"},{"issue":"1","key":"948_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/scipharm88010016","volume":"88","author":"M Mishchenko","year":"2020","unstructured":"Mishchenko M et al (2020) Thiazole-bearing 4-thiazolidinones as new anticonvulsant agents. Sci Pharm 88(1):16","journal-title":"Sci Pharm"},{"issue":"10","key":"948_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400357","volume":"357","author":"E Davydov","year":"2024","unstructured":"Davydov E et al (2024) Evaluation of thiopyrano [2, 3-d] thiazole derivatives as potential anticonvulsant agents. Arch Pharm 357(10):e2400357","journal-title":"Arch Pharm"},{"issue":"37","key":"948_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202503224","volume":"10","author":"S Khalid","year":"2025","unstructured":"Khalid S et al (2025) Facile synthesis of thiophen-2-ylmethyl 5-phenylfuran-2-carboxylates through SMC reaction: assessing their anti-seizure potential and molecular docking studies. ChemistrySelect 10(37):e03224","journal-title":"ChemistrySelect"},{"key":"948_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-981-19-5343-9_14","volume-title":"Introduction to basics of pharmacology and toxicology: volume 3: experimental pharmacology: research methodology and biostatistics","author":"J Balamurugam","year":"2022","unstructured":"Balamurugam J, Lakshmanan M (2022) Screening methods for the evaluation of antiepileptic drugs. Introduction to basics of pharmacology and toxicology: volume 3: experimental pharmacology: research methodology and biostatistics. Springer, pp 183\u2013204"},{"key":"948_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2026.108960","volume":"123","author":"MN Anjum","year":"2026","unstructured":"Anjum MN et al (2026) Discovery of potent ALK tyrosine kinase inhibitors for thyroid cancer via machine learning modeling, molecular docking, MD simulations, and DFT study. Comput Biol Chem 123:108960","journal-title":"Comput Biol Chem"},{"issue":"21","key":"948_CR30","doi-asserted-by":"publisher","first-page":"9824","DOI":"10.1021\/acs.jmedchem.9b01220","volume":"62","author":"M Gupta","year":"2019","unstructured":"Gupta M et al (2019) The blood\u2013brain barrier (BBB) score. J Med Chem 62(21):9824\u20139836","journal-title":"J Med Chem"},{"key":"948_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2022.107066","volume":"189","author":"Z Shen","year":"2023","unstructured":"Shen Z et al (2023) Bioinformatics and network pharmacology analysis of drug targets and mechanisms related to the comorbidity of epilepsy and migraine. Epilepsy Res 189:107066","journal-title":"Epilepsy Res"},{"issue":"18","key":"948_CR32","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.3390\/nu16183061","volume":"16","author":"H Yuan","year":"2024","unstructured":"Yuan H et al (2024) Biomarkers for health functional foods in metabolic dysfunction-associated steatotic liver disorder (MASLD) prevention: an integrative analysis of network pharmacology, gut microbiota, and multi-omics. Nutrients 16(18):3061","journal-title":"Nutrients"},{"key":"948_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.phrs.2016.06.018","volume":"111","author":"P Poornima","year":"2016","unstructured":"Poornima P et al (2016) Network pharmacology of cancer: from understanding of complex interactomes to the design of multi-target specific therapeutics from nature. Pharmacol Res 111:290\u2013302","journal-title":"Pharmacol Res"},{"issue":"9","key":"948_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2024.105889","volume":"17","author":"J Hafeez","year":"2024","unstructured":"Hafeez J et al (2024) Synthesis of N, N-bis ([1, 1\u2032-biphenyl]-4-ylmethyl)-4-morpholinoaniline derivatives via SMC reaction: assessing their anti-seizure potential through electroencephalogram evaluation and molecular docking studies. Arab J Chem 17(9):105889","journal-title":"Arab J Chem"},{"key":"948_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2025.149597","volume":"1855","author":"MH Ali","year":"2025","unstructured":"Ali MH et al (2025) Probiotics and pregabalin combination prevented ictogenesis, neurobehavioral abnormalities and neurodegeneration in pentylenetetrazole kindling model of epilepsy. Brain Res 1855:149597","journal-title":"Brain Res"},{"issue":"D1","key":"948_CR36","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim S et al (2016) PubChem substance and compound databases. Nucleic Acids Res 44(D1):D1202\u2013D1213","journal-title":"Nucleic Acids Res"},{"key":"948_CR37","doi-asserted-by":"publisher","DOI":"10.4081\/jphia.2023.2517","author":"J Ekowati","year":"2023","unstructured":"Ekowati J et al (2023) Chemoinformatics approach to design and develop vanillin analogs as COX-1 inhibitor. J Public Health Afr. https:\/\/doi.org\/10.4081\/jphia.2023.2517","journal-title":"J Public Health Afr"},{"issue":"6","key":"948_CR38","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1021\/ci040123t","volume":"44","author":"LD Mendelsohn","year":"2004","unstructured":"Mendelsohn LD (2004) ChemDraw 8 ultra, windows and macintosh versions. J Chem Inf Comput Sci 44(6):2225\u20132226","journal-title":"J Chem Inf Comput Sci"},{"issue":"D1","key":"948_CR39","doi-asserted-by":"publisher","first-page":"D464","DOI":"10.1093\/nar\/gky1004","volume":"47","author":"SK Burley","year":"2019","unstructured":"Burley SK et al (2019) RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy. Nucleic Acids Res 47(D1):D464\u2013D474","journal-title":"Nucleic Acids Res"},{"key":"948_CR40","doi-asserted-by":"crossref","unstructured":"Aarthi, S., T. Keerthana, and P. Puniethaa, 3d Pharamacophore Model, Virtual Screening, Binding Affinity and Molecular Dynamics Studies of Potential Anticancerous Compounds Against Mammalian Target Rapamycin. 2023.","DOI":"10.21203\/rs.3.rs-3100361\/v1"},{"key":"948_CR41","first-page":"455","volume":"31","author":"O Trott","year":"2009","unstructured":"Trott O, Olson A (2009) Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function. Effic Optim Multithreading 31:455\u2013461","journal-title":"Effic Optim Multithreading"},{"key":"948_CR42","doi-asserted-by":"publisher","DOI":"10.1021\/ci050273j","volume-title":"Chemistry software package chemoffice ultra 2005","author":"A Zielesny","year":"2005","unstructured":"Zielesny A (2005) Chemistry software package chemoffice ultra 2005. ACS Publications"},{"issue":"12","key":"948_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/minf.202400032","volume":"43","author":"SM Ivanov","year":"2024","unstructured":"Ivanov SM et al (2024) DIGEP\u2010Pred 2.0: a web application for predicting drug\u2010induced cell signaling and gene expression changes. Mol Inform 43(12):e202400032","journal-title":"Mol Inform"},{"key":"948_CR44","doi-asserted-by":"crossref","unstructured":"Safran, M., et al., GeneCards Version 3: the human gene integrator. Database, 2010. 2010.","DOI":"10.1093\/database\/baq020"},{"issue":"1","key":"948_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","volume":"16","author":"H Heberle","year":"2015","unstructured":"Heberle H et al (2015) InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinformatics 16(1):169","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"948_CR46","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12859-016-1047-0","volume":"17","author":"J Du","year":"2016","unstructured":"Du J et al (2016) A decision analysis model for KEGG pathway analysis. BMC Bioinformatics 17(1):407","journal-title":"BMC Bioinformatics"},{"issue":"11","key":"948_CR47","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504","journal-title":"Genome Res"},{"key":"948_CR48","unstructured":"Donev, F., N. Ackovska, and A.M. Bogdanova. Signaling Pathway Analysis Using. in ICT Innovations 2024. TechConvergence: AI, Business, and Startup Synergy: 16th International Conference, ICT Innovations 2024, Ohrid, North Macedonia, September 28\u201330, 2024, Proceedings. 2025. Springer Nature."}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00948-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00948-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00948-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:02:38Z","timestamp":1792072958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00948-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["948"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00948-6","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Minor correction in funding information.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No potential conflict of interest was reported by the author(s).","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"237"}}